Skip to main content

Descubren dos genes relacionados con el consumo de cafeína
















La cantidad de cafeína consumida por la población está influida por dos genes: CYP1A2 y AHR. Así lo revela una investigación internacional que pretende averiguar si la sensibilidad que algunas personas muestran ante este estimulante tiene una base genética.


“La cantidad de café que consumimos depende, en parte, de nuestros genes”, explica a SINC Neil Caporaso, autor principal del estudio e investigador de la división de Epidemiología del Cáncer y Genética del Instituto Nacional del Cáncer (EE UU).

El trabajo, publicado en PLoS Genetics, revela la existencia de dos genes cuya variación afecta al consumo de cafeína, el estimulante más ingerido del mundo. Se trata del gen CYP1A2, implicado en el metabolismo de este estimulante, y de AHR, relacionado con la regulación del primero.

Para realizar el estudio, los autores analizaron alrededor de 100.000 marcadores genéticos de más de 40.000 personas. Los individuos con un genotipo asociado a un mayor consumo tomaron cerca de 40 miligramos más de cafeína que los que poseían un genotipo relacionado con un consumo menor, según los investigadores. Esta medida equivale a un tercio de taza de café o a una lata de refresco de cola.

Por otra parte, la cafeína no afecta por igual a todo el mundo. Este estudio también servirá para determinar si la sensibilidad a esta molécula depende de los genes. “Sabíamos tanto que la herencia genética influía en el metabolismo de la cafeína como que algunos genes la metabolizaban y ahora hemos conectado los dos conceptos”, añade Caporaso.

La cafeína está relacionada con diversas afecciones fisiológicas y médicas: interfiere en los patrones de sueño, en los niveles de energía, en el estado de ánimo y en el rendimiento mental y físico. Sin embargo, el investigador asegura que ningún científico ha encontrado “ninguna evidencia convincente de que sea perjudicial”.

“Tiene efectos secundarios si se consume en exceso porque puede provocar ansiedad, problemas del ritmo cardíaco o dificultades gastrointestinales”, reconoce Caporaso.

Además, el gen que metaboliza este estimulante también activa otras hormonas e incluso productos químicos que causan cáncer, como las aminas aromáticas localizadas en los cigarrillos. “Vamos a estudiar los dos genes que hemos descubierto para identificar a la población con un mayor riesgo de sufrir tumores”, concluye el experto. (Fuente: SINC)
http://noticiasdelaciencia.com/not/847/descubren_dos_genes_relacionados_con_el_consumo_de_cafeina/

Comments

Popular posts from this blog

Nordic Walking Benefits, ADHD and Diet, Supplements and Cancer, Sources of Fiber

A Better Way To Walk: Nordic Walking Improves Quality of Life, Depression, and Functional Capacity SciTechDaily Reference: “Sustained Effects of Different Exercise Modalities on Physical and Mental Health in Patients With Coronary Artery Disease: A Randomized ... Dietary Interventions for ADHD: Emerging Research and Considerations There has been increasing interest in the role that diet and supplements play in the treatment of attention-deficit/hyperactivity disorder (ADHD) symptoms, from patients and researchers alike. Diet is an important treatment approach to consider, as it is a lifestyle change rather than a medication. Additionally, at least 10% to 30% of children with ADHD are non-responsive to, or experience adverse effects from, ADHD medications­­­­.1 A dietary approach to ADHD can be complementary to a conventional pharmacological approach, giving patients and their families more options toward a personalized treatment plan. This article will examine current research about di

More People Are Microdosing for Mental Health. But Does It Work?

By Dana G Smith. Joseph started microdosing psychedelics five years ago to try to improve his mental health. “I was just kind of in this depression, in this rut,” he said. “I was unhappy and angry and agitated all the time, and it went against the way that I saw myself.” Depression and anxiety run in Joseph’s family, and he’d been prescribed Prozac as a kid. But when symptoms of depression returned in his early 30s, he didn’t want to go back to a prescription drug. Joseph, an Austin-based designer (he asked to withhold his full name, citing privacy concerns surrounding mental health issues and illegal drug use), came across research from Johns Hopkins University about psilocybin, the active ingredient in hallucinogenic, or “magic,” mushrooms. In a small study, full doses of the drug helped cancer patients cope with depression and anxiety. Then he read anecdotes of Silicon Valley influencers claiming increased energy from taking tiny doses of psychedelics. So he decided to start microdo

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable